Companies at COBIS

Agrobiomics develops biological solutions for sustainable agriculture

Prediction of how likely any given oncology drug is to benefit individual cancer patients, allowing informed choices for doctors and patients, better patient outcomes and reduced costs. Uses AI/ML applied to the gene expression patterns of the patient´s tumor. Can in principle predict ALL drugs from one biopsy. Independent of biomarkers.

We help parents give their children the best start in life, with personalised health recommendations based on microbiome testing and health risk analysis. Our offering includes microbiome tests, detailed reports, personalised lifestyle recommendations and consultations, based on the latest science.

Quantum Random Number Generation

We convert the power of selective fibroblast modulation into transformative therapeutics. Pathologically activated fibroblasts orchestrate abnormal tissue structure and drive many diseases. Our technology modulates of disease-associated fibroblasts with unprecedented selectivity, resulting in precise tissue remodeling and normalization, and generat

Ampa Medical is developing a new solution for people with ileostomy. Our vision is to provide users with an alternative to the stoma bag giving them more freedom, control and comfort in everyday life.

Analona Therapeutics develops novel therapies for pancreatic cancer, a disease for which there are currently no adequate treatment options. Our team is comprised of experienced cancer researchers, biotech professionals and entrepreneurs, who work together to create innovation in cancer treatment.

Ankrin Therapeutics is a biotech start-up developing first-in-class drugs for cancer treatment. Our novel and unique therapeutic strategies, founded on forefront high quality research in cancer biology, target essential protein-protein interactions required for error-free DNA damage repair.

At ArcanaBio, we are developing innovative biophotonic technologies that enable everyday biomarker testing, supporting early disease detection and help advance next-generation proteomics research.

Avilex Pharma is developing novel inhibitors of PDZ domains to target a range of unmet medical needs.

BGI was founded in 1999 as a nonprofit research organization to support the Human Genome Project. Over the years, BGI has grown into a multi-national genomics company with significant global operations, including sequencing laboratories based in the US, Europe, Hong Kong and mainland China. BGI Europe’s headquarters were established in Copenhagen, Denmark, in 2010. Our experience in high-capacity, high- throughput analytics, bioinformatics capabilities, and our long history in large population–scale genomics and data analysis, means that BGI Europe is uniquely positioned to support both academic institutions and pharmaceutical companies with a wide array of high quality genomic services for basic research, pharmacogenomics and clinical diagnostics.

Loma Therapeutics develops a novel immunotherapy to treat HPV and HPV-associated cancer

The BioInnovation Institute offers entrepreneurs and researchers in life science help to bring interdisciplinary ideas to life and research to market. Through providing networks, support, facilities, and funding.BII embraces every phase of a life-science start-up company and though we are based in Denmark, our aspirations are international. BII is a Novo Nordisk Foundation initiative.

As your trusted strategic partner, it is our mission to positively impact a sustainable life science ecosystem connecting deep knowledge, cutting-edge technologies, and highly skilled personnel. We are dedicated to delivering on the drug discovery, early drug development and manufacturing goals of the biotech and pharma industry.

BioPhenyx is the first company in the world that accurately and experimentally determines how genetic sequence variants/mutations (“what is coded?”) impact cell phenotypes (“what happens?”).

dawn-bio is pioneering women’s reproductive health through a proprietary screening platform that unleashed fertility drug development. We have already discovered molecules showing multi-fold improvement in embryo development and uterus implantation to initially improve IVF outcomes and much more.

Dedicated to develop novel stem cell therapies to treat chronic diseases. We have discovered that one specific cell type, dubbed ‘blue cells’ has remarkable clinical effects in multiple diseases- we have found that a single injection of the patients own ADRCs reversed erectile dysfunction in prostatectomized men.

Precision probiotics for PFAS detoxification

Our company is engaging on organic food certification and consulting service to the organic food producers and exporters here from EU to China, as it is mandatory to be approved and get the Chinese organic certificate for export to China from EU, so we help our clients here in EU to get the certificate.

Developing next generation biological crop protection using microbial consortia to protect crops against diseases and improve crop health and resilience. Spin out of KU and DTU. Grant funded by BII under the BioFaculty (BioStudio) programme 2021 - 2024.

Venture from Novozymes producing cell culture media ingredients.

The aim of Cymab is to develop a groundbreaking class of antibody therapies for treatment of non-immunogenic tumors.

DARERL revolutionizes medical device manufacturing by offering digital representations of human anatomies for computerized design and clinical testing.Developing and testing new medical devices traditionally involves costly and time-consuming incremental tests of physical prototypes. These tests carry a high risk of delays or unsuccessful regulat

Defensin Therapeutics is a Danish biopharmaceutical company spun out from Novozymes A/S in 2013. Defensin Therapeutics focuses on the development and commercialization of novel products for the treatment of diseases and conditions associated with dysregulation of the human microbiota.

Domisphere ApS is a spin-off from the company INFUSER ApS, which is active within air cleaning and surface disinfection. Domisphere ApS develop and market patented indoor air purification technologies and solutions based on photonics and catalytical principles. The indoor air purification solutions target both the BtB and BtC market segments, internationally.

We are Droplet IV and we have invented an automatic flushing device for IV Lines - making sure patients get the full dose of medicine every time while alleviating nurses and aiding the fight against antimicrobial resistance.

EIT Health Scandinavia is the Scandinavian node of EIT Health, the largest organized collaboration within life sciences and Health in Europe. EIT Health Scandinavia has Offices in Copenhagen-Denmark, Stockholm-Sweden and Tartu-Estonia. Our operations covers Diital Health, MedTech and Biotech and we run various pan-European programs.

Enduro makes bioproduction scalable using our game-changing platform technology Enduro Sense. Enduro Sense is seamlessly introduced by biomanufacturers as a genetic “plugin” powered by biosensors. It permits only highly productive cells to grow, rendering production stable to scale.

The European Spallation Source (ESS) ERIC is a multi-national collaboration that is currently constructing the world’s brightest neutron scattering research facility in Lund, Sweden. The Data Management and Software Centre (DMSC), located in Copenhagen, Denmark, is an ESS Division that is responsible for developing the data acquisition, reduction, visualization and analysis software for the ESS neutron beam instruments, and for storing, and making available, the scientific research data taken at the ESS when it is operational.The ESS will be up to 100 times brighter than today’s leading neutron scattering facilities, enabling new opportunities for researchers in the fields of life sciences, energy, environmental technology, cultural heritage and fundamental physics.

Talk to the doctor when and where it suits you. With Eyr, you take your medical time on mobile - quickly, easily and securely.

Fischer BioConsult provides services relating to financing, business development and product development within the biotech sector. Per Fischer has more than 15 years experience from biotech, pharma and consulting, and has worked for more than 25 clients over a period of 4 years.

FÆRM develops enzymes, coagulation, and fermentation technologies for future plant-based cheese alternatives. FÆRMs technology is used by dairies, to produce cheese alternatives that taste, look like, and behave like traditional cheese – based on protein-rich legumes.

At Glaze Life Sciences, we´re revolutionizing diabetes care. We believe that frequent testing is key to slow down diabetes progression.We are developing a truly non-invasive device to monitor your blood glucose.We shine terahertz light on your skin, it reaches glucose in the interstitial fluid and advanced AI models measure your glucose.

GlioRay develops advanced radioligand therapies for brain cancer.

Helion Biotech is a drug development company based in Copenhagen, Denmark, with the aim of developing a recombinant protein, MASP-2, from the immune system for therapeutic use initially in supportive care in cancer. MASP-2 is a central component of the immediate and innate immune defense against micro-organisms. The primary targeted indication is prevention of infectious episodes in MASP-2-deficient patients undergoing chemotherapy.

Intelligent communication, task and workflow platform for Healthcare.

At HHC Medical we are developing a technology platform to transform the delivery of therapies in patients across an extensive spectrum of diseases.

Innovayt is an innovation consultancy, specialising in identifying relevant funding opportunities and preparing high-quality funding applications to help clients drive global progress through innovation.We work with grants as well as with loans, equity, and tax incentives for innovation.

Notifytherapeutics.comDeveloping a new treatment for infertile women not benefitting from todays hormone-based standard fertility treatment

Invitreo specialises in materialising deep technology healthcare research through academia-industry collaboration

ISD-Immunotech is developing a STING pathway modulator as a first-in-class treatment for Systemic Lupus Erythematosus (SLE) and other autoimmune diseases where the STING pathway is clearly shown to be implicated in the pathogenesis of the disease. ISD is a spin-out of Aarhus University and is run by a team of experienced pharmaceutical experts and business leaders with a solid track record of successful drug development.

At Leopard Biosciences, we are democratizing diagnostics by bringing the power of molecular testing in the hands of doctors and patients. To accomplish this, we are commercializing a new CRISPR platform that enables multiplex detection of DNA and RNA biomarkers with the ease-of-use of Lateral Flow Assays.

Loma Therapeutics is developing a best-in-class HPV-targeted immunotherapy, which can benefit patients with HPV infection, dysplasia and cancer.

Services of all kinds of in-house IP Management. Works as a trusted consultant helping you to manage your IP activities.The service is a supplement to your Patent Attorney to achieve improvement of your IP investment by developing the best protection strategies for your business, align IP, so you can translate IP opportunities into business values

Mello is developing a unique encapsulation delivery technology to limit viability loss and enhance efficacy potential of probiotics (including live biotherapeutics / nextgen probiotics) during downstream travel to target location, when applied within food and drink.

metaLead revolutionizes the way medicine treats toxic metals and metal-related diseases, one metal at a time.

Metsystem is developing a cancer metastasis prognosis platform for breast cancer patients capable of predicting each indiviual patient´s risk of metastasis and guide preventative treatment.

Our experienced team are pioneers in life sciences patents. We combine years of experience with creative, fresh thinking to design IP strategies that work in a changing world. We´re active in emerging technical areas - bioinformatics, plants, antibodies/ADCs, vaccines, advanced therapeutics, precision medicine, microbiome, quantum computing and AI.

We valorize organic residuals from the food and agricultural sector by transforming organic waste products into protein-rich and nutritious food ingredients. We do this by growing edible filamentous fungi in a novel bioreactor system for solid-state fermentation, with minimal water and energy consumption.

MyoPax is an early clinical stage biotech. We restore muscle function with muscle stem cells. Muscle wasting is caused by common diseases, trauma or genetic mutations. It leads to loss of personal autonomy and premature death. The MyoPax´ platform combines our patented technology to produce potent muscle stem cells with virus free gene engineering.

Naturpladen develops and produces regenerative building materials using plant-fungal mycelium-composites.

At NordicBlue, we are on a mission to eliminate the hazardous chemicals from the jeans you are wearing. We want to empower the global textile industry with eco-efficient dyeing methods that prioritize sustainability and quality and protect our planet and our textile workers. That’s why we develop eco-friendly, socially responsible, and economically

NVP aims to accelerate the cultured meat revolution by introducing our ground-breaking ‘BoSat Proliferate’ for the propagation of meat cells. The sustainability of our product and low cost will further optimize the production and therefore allow the world to continue eating meat without the ethical and environmental issues that today surrou

NorFalk rethinks the production of soap, cosmetics and detergents by producing sustainable active andstabilizing ingredients called surfactants. We will do that by using biotechnology as a tool to transformthese ingredients in our everyday consumer products into more sustainable products that do not affectour planet as much.

Oasicare´s vision is to improve women’s health during and post partum on a global scale. Our first solution is a medical device to reduce the risk of birth ruptures.

Single cell spatial proteomics to radically improve precision medicine and patient care

Orphazyme develops pharmaceuticals that target lysosomes. The company is dedicated to developing a novel class of therapeutics for the treatment of lysosomal storage diseases, a group of debilitating genetic disorders.

Ousia Pharma is a biotech spin-out from the University of Copenhagen developing novel peptide-drug conjugates for treatment of obesity and metabolic diseases.

Dedicated to improving life quality for millions of people suffering from diabetes, Pancryos is developing a next generation stem cell derived cell therapy PanINSULA™

Papermill Medical is a globally operating medical and scientific consultancy that provides services for companies and organizations in the life science industries including pharma, biotech and diagnostics. Based on a proven track record in R&D and commercial functions of the pharmaceutical industry Papermill Medical can support clients in different tasks such as:R&D strategy development and implementationNon-clinical pharmacologyScientific evaluation and value proposition development of early stage research opportunitiesProject managementPublication strategy development and implementationPreparation and editing of scientific and medical publications such as manuscripts, scientific and commercial presentations, registration files, market access value proposition and value dossiers

Developing high speed interconnect technology for a greener, faster internet infrastructure.

Pharmista Technologies aims to revolutionize the pregnancy testing market through developing the world´s first reusable pregnancy test and thereby address the shortcomings of current single-use tests. When successful, we will apply the technology in other diagnostic areas with the goal of disrupting the immunoassay market as a whole.

Polyceutix is a DTU spinout, with the aim of using advances in polymer chemistry to transform cancer immunotherapy.

PreTT is a pioneer in advancing pretargeted radioimmunotherapy. With our proprietary technology, we are on a journey to improve the lives of millions of cancer patients.

Precision oncology therapeutics company developing targeted treatments for breast cancer brain metastatic patients

Quantum Exponential stands out as a specialised investment company exclusively focused on investing in quantum technology and quantum technology startups. Our mission is to invest patient capital in 100% quantum technology pre-seed, seed, Series A, and some Series B funding rounds.

QunaSys is the world’s leading developer of innovative algorithms in chemistry focused onaccelerating the development of quantum technology applicability. Founded in 2018 in Japan,QunaSys is now expanding internationally and has opened an office in Denmark.

ROS Therapeutics is a development stage company committed to optimize the treatment experience for small people suffering from chronic inflammatory diseases. Market research indicates that Trexior™ may be able to transform MTX care.

LAB HOS is a company devoted to the design, develop and marketing of high-tech instruments for clinical testing and healthcare for labs and hospitals. We’re able to satisfy the exacting quality standards required by these industries thanks to the experience and expertise of our team. We are working in1. Lab section: we declare the best quality materials and high tech instrument to labs and IVO manufacturers, for example all reagents and instruments being used in immunoassay based clinical tests in medical and veterinary fields.2. Hospital section: we provide the EU approved facilities being used in patient caring like parts used in making bed hospital, different types of hospital and lab washing machines. Moreover, in clinical diagnostic section, we present PC based audiometers.

Sevenless therapeutics has used state of the art mathematical modelling to identify a drug target in a pain signalling pathway. Our aim is to deliver a novel drug for clinical evaluation in osteoarthritis pain, within 18 months.

Sqale ApSAccelerated delivery of biopharmaceuticals through quantum-enhanced re-launchable and reusable manufacturing

Stimuliver is a prospective start-up that aims to generate at clinical grade, human stem cell-derived liver tissue to treat liver disease, specifically hepatic insufficiency. Our disruptive technology that we developed could potentially reduce the need for organ donation to treat chronic disease.

At Sulis Therapeutics, we´re pioneering new treatments for systemic sclerosis and other diseases of inflammation and fibrosis. Inspired by Sulis, the Celtic goddess of healing and strength, and based on a deep understanding of the molecular pathways that drive these diseases, our lead program is based around potent and selective inhibitors of STING

We prevent chronic stress and treat your stress with mindfulness.Individuals under high levels of pressure at work are 45 percent more likely to develop type 2 diabetes compared to those experiencing lower stress levels. According to WHO “Stress would be the main source of diseases by 2020´´. We are solving #1 problem of our society and while doing that, we are helping them by being happy.

SymbioMatch specialises in the production of tailor-made biofertilisers for specific soil types and legume crops. Our innovative technology enables us to identify the optimal combination of plant, soil, and symbiotic bacteria to naturally enhance soil fertility and increase crop yield.

Tetrakit Technologies develops the next generation of radioactive drugs to find and destroy cancer tumors.

Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. The company was founded in 2020 with funding from HealthCap and Novo Seeds.

At TriptoBIO we are developing a yeast production platform for producing high value plant molecules.Our first product will liberate the world from rat poison, by supporting safe rat sex.

VEIL.AI – the mostexperienced European health tech company in health data anonymization – hasdeveloped next generation AI-based anonymization technology that brings thequality of anonymized health data to the next level. Great new possibilitiesfor e.g. in transborder data collaborations, RWE, RCT, algorithm developmentand hospital data lakes.

Vores mission er at være pionere inden for bæredygtige løsninger til vejkonstruktion ved at erstatte traditionel asfalt med banebrydende regenerative materialer.

Non-intrusive, long term monitoring of middle ear health